Display options
Share it on

Korean J Urol. 2012 Jul;53(7):487-91. doi: 10.4111/kju.2012.53.7.487. Epub 2012 Jul 19.

Bladder Wall Thickness is Associated with Responsiveness of Storage Symptoms to Alpha-Blockers in Men with Lower Urinary Tract Symptoms.

Korean journal of urology

Jung Soo Park, Ho Won Lee, Seung Wook Lee, Hong Sang Moon, Hae Young Park, Yong Tae Kim

Affiliations

  1. Department of Urology, Hanyang University College of Medicine, Seoul, Korea.

PMID: 22866221 PMCID: PMC3406196 DOI: 10.4111/kju.2012.53.7.487

Abstract

PURPOSE: Bladder wall thickness (BWT) is reported to be related to detrusor overactivity and bladder outlet obstruction. We investigated the relationship between BWT and the responsiveness of storage symptoms to alpha-blockers in men with lower urinary tract symptoms (LUTS).

MATERIALS AND METHODS: A total of 74 patients with LUTS were enrolled. International Prostate Symptom Score, uroflowmetry with post-void residual urine volume, and transrectal ultrasonography (TRUS) were investigated. BWT was measured by performing TRUS at the midsagittal plane view, and the average value of BWT at the anterior, dome, and trigone areas was used. After 4 weeks of alpha-blocker medication, patients were reevaluated and divided into two groups. The responder group consisted of patients who reported improvement in the storage symptom subscore of 2 points or more; the non-responder group consisted of patients who reported improvement of less than 2 points. Clinical parameters including BWT were compared between the two groups.

RESULTS: A total of 52 patients were followed. BWT was positively correlated with intravesical prostate protrusion (IPP) (9.26±4.99, standardized beta=0.393, p=0.002) and storage symptom subscore (0.35±0.43, standardized beta=0.458, p=0.002). Compared with that in the responder group, BWT was thicker in the non-responder group, and improvement in the storage symptom score was correlated with BWT (0.58±0.09 cm vs. 0.65±0.11 cm, p=0.018) and prostate volume (27.08±16.26 ml vs. 36.44±10.1 ml, p=0.018).

CONCLUSIONS: BWT was correlated with IPP, the storage symptom subscore, and the responsiveness of storage symptoms to alpha-blockers in LUTS/benign prostatic hyperplasia (BPH) patients. As BWT increased, the responsiveness of storage symptoms to alpha-blocker decreased in LUTS/BPH patients.

Keywords: Adrenergic alpha-antagonists; Lower urinary tract symptoms; Muscarinic antagonists

References

  1. Neurourol Urodyn. 2000;19(5):609-29 - PubMed
  2. Int J Impot Res. 2008 Dec;20 Suppl 3:S33-43 - PubMed
  3. J Urol. 2006 Mar;175(3 Pt 1):999-1004; discussion 1004 - PubMed
  4. BJU Int. 2004 Oct;94(6):817-20 - PubMed
  5. J Urol. 1993 Nov;150(5 Pt 2):1681-95 - PubMed
  6. Ultrasound Obstet Gynecol. 1994 May 1;4(3):220-3 - PubMed
  7. J Urol. 1998 Jan;159(1):191-4 - PubMed
  8. Eur Urol. 2007 Sep;52(3):827-34 - PubMed
  9. World J Urol. 2002 Apr;19(6):443-52 - PubMed
  10. J Urol. 2010 Nov;184(5):1847-54 - PubMed
  11. Urology. 1996 Jun;47(6):942-7 - PubMed
  12. J Urol. 1982 Dec;128(6):1340-2 - PubMed
  13. Korean J Urol. 2012 Jan;53(1):23-8 - PubMed
  14. J Urol. 2005 Dec;174(6):2273-5. discussion 2275-6 - PubMed
  15. Ultrasound Obstet Gynecol. 2008 Sep;32(4):535-9 - PubMed
  16. J Urol. 2011 May;185(5):1793-803 - PubMed
  17. Br J Obstet Gynaecol. 1996 Sep;103(9):904-8 - PubMed
  18. Int J Urol. 2010 Jan;17(1):69-74 - PubMed
  19. AJR Am J Roentgenol. 1987 Sep;149(3):563-6 - PubMed
  20. Korean J Urol. 2010 Apr;51(4):281-6 - PubMed
  21. Neurourol Urodyn. 2011 Nov;30(8):1422-8 - PubMed
  22. J Urol. 1998 Mar;159(3):761-5 - PubMed
  23. J Urol. 1997 Feb;157(2):476-9 - PubMed
  24. Neurourol Urodyn. 2000;19(5):585-93 - PubMed
  25. J Urol. 2006 Jun;175(6):2170-3 - PubMed
  26. Int Urogynecol J. 2010 Nov;21(11):1405-11 - PubMed
  27. J Urol. 1986 Jun;135(6):1284-9 - PubMed

Publication Types